Tamara A Kucaba

Author PubWeight™ 11.63^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	CD8 T cells utilize TRAIL to control influenza virus infection.	J Immunol	2008	1.75
2	TRAIL gene therapy: from preclinical development to clinical application.	Curr Gene Ther	2009	1.13
3	1274 full-open reading frames of transcripts expressed in the developing mouse nervous system.	Genome Res	2004	1.08
4	Eradication of metastatic renal cell carcinoma after adenovirus-encoded TNF-related apoptosis-inducing ligand (TRAIL)/CpG immunotherapy.	PLoS One	2012	1.00
5	Activation-induced CD154 expression abrogates tolerance induced by apoptotic cells.	J Immunol	2009	0.90
6	Sensitization of human bladder tumor cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis with a small molecule IAP antagonist.	Apoptosis	2011	0.87
7	Influenza-induced expression of functional tumor necrosis factor-related apoptosis-inducing ligand on human peripheral blood mononuclear cells.	Hum Immunol	2008	0.87
8	Systemic immunological tolerance to ocular antigens is mediated by TRAIL-expressing CD8+ T cells.	J Immunol	2010	0.87
9	CpG-mediated modulation of MDSC contributes to the efficacy of Ad5-TRAIL therapy against renal cell carcinoma.	Cancer Immunol Immunother	2014	0.82
10	TRAIL-expressing CD8+ T cells mediate tolerance following soluble peptide-induced peripheral T cell deletion.	J Leukoc Biol	2010	0.81
11	Effective TRAIL-based immunotherapy requires both plasmacytoid and CD8α dendritic cells.	Cancer Immunol Immunother	2014	0.77
12	[Not Available].	J Oncol	2009	0.75